EXHIBIT 10(i)Consulting Agreement • March 19th, 2004 • Marc Pharmaceuticals Inc • New York
Contract Type FiledMarch 19th, 2004 Company Jurisdiction
EXHIBIT 10(k) SUBSCRIPTION AGREEMENT To: Marc Pharmaceuticals, Inc. The undersigned, ________________________ (print name(s)) hereby acknowledges receipt of the prospectus, dated [_____________], of Marc Pharmaceuticals, Inc. (the "Company") and...Subscription Agreement • July 8th, 2004 • Marc Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledJuly 8th, 2004 Company Industry
WITNESSETH:Employment Agreement • March 19th, 2004 • Marc Pharmaceuticals Inc
Contract Type FiledMarch 19th, 2004 Company
EXHIBIT 10(g) ESCROW AGREEMENTEscrow Agreement • July 8th, 2004 • Marc Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJuly 8th, 2004 Company Industry Jurisdiction
EXHIBIT 10.21Consulting Agreement • May 16th, 2005 • Marc Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
Contract Type FiledMay 16th, 2005 Company Industry Jurisdiction
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ISSUED UNDER AND ARE GOVERNED BY AND ARE SUBJECT TO THAT CERTAIN WARRANT AGREEMENT, DATED AS OF ____________, 2004, A COPY OF SUCH WARRANT AGREEMENT WILL BE FURNISHED BY THE COMPANY TO THE...Marc Pharmaceuticals Inc • July 8th, 2004 • Pharmaceutical preparations • New York
Company FiledJuly 8th, 2004 Industry JurisdictionTHIS CERTIFIES that, for value received, ________________________ (including any permitted transferee, the "Holder"), is entitled to subscribe for and purchase from Marc Pharmaceuticals, Inc., a Delaware corporation (the "Company"), upon the terms and conditions set forth herein, at any time from the date hereof to any time before 5:00 P.M. on [____________], 2009, New York, New York time (the "Exercise Period"), the number of shares specified above of the Company's common stock, $0.0001 par value per share (the "Common Stock"), at an exercise price equal to $.50 per Share (the "Exercise Price"). As used herein, the term "this Warrant" shall mean and include this Warrant and any Warrant or Warrants hereafter issued as a consequence of the exercise or transfer of this Warrant in whole or in part.
FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • August 3rd, 2004 • Marc Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledAugust 3rd, 2004 Company Industry
EXHIBIT 10(o) AGREEMENT OF USEAgreement of Use • March 19th, 2004 • Marc Pharmaceuticals Inc • Connecticut
Contract Type FiledMarch 19th, 2004 Company Jurisdiction
PLACEMENT AGENT REGISTRATION RIGHTS AGREEMENT THIS PLACEMENT AGENT REGISTRATION RIGHTS AGREEMENT (this "Agreement") dated __________ 2004 is entered into by and between Marc Pharmaceuticals, Inc. (the "Company") and Wien Securities Corp. (the...Placement Agent Registration Rights Agreement • August 3rd, 2004 • Marc Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 3rd, 2004 Company Industry Jurisdiction
March 1, 2005 Ms. Barbara Pifel Ms. Audrey Schwimmer Mr. Derek Spears Weill Medical College of Cornell University Office of Research & Sponsored Programs 1300 York Avenue, Room A-131 New York, NY 10021 Dr. Brij B. Saxena 515 East 71st Street, Room 412...Marc Pharmaceuticals Inc • March 31st, 2005 • Pharmaceutical preparations
Company FiledMarch 31st, 2005 Industry
July 9, 2004 Ms. Barbara Pifel Ms. Audrey Schwimmer Mr. Derek Spears Weill Medical College of Cornell University Office of Research & Sponsored Programs 1300 York Avenue, Room A-131 New York, NY 10021 Dr. Brij B. Saxena 515 East 71st Street, Room 412...Marc Pharmaceuticals Inc • August 3rd, 2004 • Pharmaceutical preparations
Company FiledAugust 3rd, 2004 IndustryThis letter is to confirm our understanding that the first payment to be made under the Agreement, pursuant to Section 4.1 which provides that $187,500 shall be paid by June 30, 2004, shall instead be paid by as follows: $75,000 by July 15, 2004 and $112,500 by November 12, 2004.
EXHIBIT 10(f) Schedule 10(f) identifying lock-up agreements that are substantially similar to Exhibit 10(e) in all material respects except as to the parties thereto and the amount of shares of common stock of the company that are locked up. Total...Marc Pharmaceuticals Inc • March 19th, 2004
Company FiledMarch 19th, 2004
BETWEEN MARC PHARMACEUTICALS, INC. (SPONSOR) AND WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY (WMC)Sponsored Research Agreement • March 19th, 2004 • Marc Pharmaceuticals Inc
Contract Type FiledMarch 19th, 2004 Company
MARC LOGO] June 29, 2005 Ms. Barbara Pifel Weill Medical College of Cornell University Senior Director of Grants & Contracts 1300 York Avenue, Box 89 New York, NY 10021 Re: Sponsored Research Agreement between Marc Pharmaceuticals, Inc. and Weill...Marc Pharmaceuticals Inc • August 22nd, 2005 • Pharmaceutical preparations
Company FiledAugust 22nd, 2005 IndustryMs. Barbara Pifel Weill Medical College of Cornell University Senior Director of Grants & Contracts 1300 York Avenue, Box 89 New York, NY 10021
8/17/02 9/30/05 $350,000 $125,000 --------------------------------------------- ----------------------------------------- 11/7/04 9/30/05 $25,000 ------------- ------------------------------------------------------------------------- 2/3/05 9/30/05...Marc Pharmaceuticals Inc • March 31st, 2005 • Pharmaceutical preparations
Company FiledMarch 31st, 2005 Industry
BETWEEN MARC PHARMACEUTICALS, INC. (SPONSOR) AND WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY (WMC) BRIJ B. SAXENASponsored Research Agreement • March 19th, 2004 • Marc Pharmaceuticals Inc
Contract Type FiledMarch 19th, 2004 Company
Ms. Barbara Pifel Weill Medical College of Cornell UniversityMarc Pharmaceuticals Inc • November 21st, 2005 • Pharmaceutical preparations
Company FiledNovember 21st, 2005 Industry
MARC PHARMACEUTICALS PLACEMENT AGREEMENTMarc Pharmaceuticals • August 3rd, 2004 • Marc Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 3rd, 2004 Company Industry Jurisdiction
Exhibit 10.19 ALLONGE THIS ALLONGE to the Promissory Note (the "Note") in the original principal sum of $__________, dated ______________, 200__, made by Marc Pharmaceuticals, Inc., payable to __________________hereby amends the Note to provide that...Marc Pharmaceuticals Inc • March 31st, 2005 • Pharmaceutical preparations
Company FiledMarch 31st, 2005 Industry
EXHIBIT 10.23 August 1, 2005 Ms. Barbara Pifel Ms. Audrey Schwimmer Mr. Derek Spears Weill Medical College of Cornell University Office of Research & Sponsored Programs 1300 York Avenue, Room A-131 New York, NY 10021 Dr. Brij Saxena Weill Medical...Marc Pharmaceuticals Inc • August 24th, 2005 • Pharmaceutical preparations
Company FiledAugust 24th, 2005 IndustryThis letter is to confirm our understanding that the second payment to be made under the Agreement, pursuant to section 4.1 which provided that $187,500 shall be paid by July 1, 2005, shall be revised as follows: $50,000 shall be paid by August 16, 2005, $68,750 shall be paid by September 16, 2005 and $68,750 shall be paid by October 16, 2005.
October 14, 2005 Ms. Barbara Pifel Weill Medical College of Cornell University Senior Director of Grants & ContractsMarc Pharmaceuticals Inc • November 21st, 2005 • Pharmaceutical preparations
Company FiledNovember 21st, 2005 Industry
October 14, 2005 Ms. Barbara Pifel Weill Medical College of Cornell University Senior Director of Grants & ContractsMarc Pharmaceuticals Inc • November 21st, 2005 • Pharmaceutical preparations
Company FiledNovember 21st, 2005 Industry
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ISSUED UNDER AND ARE GOVERNED BY AND ARE SUBJECT TO THAT CERTAIN WARRANT AGREEMENT, DATED AS OF ____________, 2004, A COPY OF SUCH WARRANT AGREEMENT WILL BE FURNISHED BY THE COMPANY TO THE...Marc Pharmaceuticals Inc • July 8th, 2004 • Pharmaceutical preparations • New York
Company FiledJuly 8th, 2004 Industry JurisdictionTHIS CERTIFIES that, for value received, ________________________ (including any permitted transferee, the "Holder"), is entitled to subscribe for and purchase from Marc Pharmaceuticals, Inc., a Delaware corporation (the "Company"), upon the terms and conditions set forth herein, at any time from the date hereof to any time before 5:00 P.M. on [___________], 2011, New York, New York time (the "Exercise Period"), the number of shares specified above of the Company's common stock, $0.0001 par value per share (the "Common Stock"), at an exercise price equal to $1.00 per Share (the "Exercise Price"). As used herein, the term "this Warrant" shall mean and include this Warrant and any Warrant or Warrants hereafter issued as a consequence of the exercise or transfer of this Warrant in whole or in part.
EXHIBIT 10(h)Warrant Agreement • July 8th, 2004 • Marc Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJuly 8th, 2004 Company Industry Jurisdiction